Carvedilol vs Durvalumab

Carvedilol vs Durvalumab: Overview

This comparison examines the pharmacological differences between Carvedilol and Durvalumab.

Mechanism of Action

Carvedilol: Non-selective beta-blocker with alpha-1 blocking activity.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Carvedilol — 7-10 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Carvedilol — C24H26N2O4.

Molecular Weight: Carvedilol — 406.4740 g/mol.

Type: Carvedilol — Small molecule; Durvalumab — Antibody.